Accendra HealthACH +0.28%61 ROC (Joel Greenblatt) % is 18.54% as of Mar. 2026, which is 97% above its 10-year median of 9.39. GuruFocus rates ACH with a GF Score™ of 61/100 and a GF Value™ of $5.02 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 118 Medical Distribution companies, Accendra Health ranks worse than 78.81% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Accendra Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 18.54%.
The historical rank and industry rank for Accendra Health's ROC (Joel Greenblatt) % or its related term are showing as below:
ACH'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -30.99 Med: 9.39 Max: 24.98
Current: 0.49
During the past 13 years, Accendra Health's highest ROC (Joel Greenblatt) % was 24.98%. The lowest was -30.99%. And the median was 9.39%.
ACH's ROC (Joel Greenblatt) % is ranked worse than 78.81% of 118
companies
in the Medical Distribution industry
Industry Median: 15.345
vs ACH: 0.49
Accendra Health's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
Accendra Health (NYSE:ACH) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Accendra Health ROC (Joel Greenblatt) % Related Terms
Accendra Health ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Accendra Health's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ACH vs FOCL, YI, COSM: ROC (Joel Greenblatt) % Comparison
For the Medical Distribution subindustry, Accendra Health's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accendra Health ROC (Joel Greenblatt) % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Accendra Health's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Accendra Health's ROC (Joel Greenblatt) % falls into.
Accendra Health ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 18.54% mean?
Accendra Health (ACH) has a ROC (Joel Greenblatt) % of 18.54% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Accendra Health and its competitors. This is 97% above median its historical median of 9.39. According to the industry distribution chart, Accendra Health ranks #93 out of 118 companies in the Medical Distribution industry, placing it in the top 78.8%.
Is Accendra Health's ROC (Joel Greenblatt) % too high?
Accendra Health's current ROC (Joel Greenblatt) % of 18.54% is 97% above median its 10-year median of 9.39. The Medical Distribution industry median ROC (Joel Greenblatt) % is 15.35. Accendra Health's value of 18.54% is 20.8% above this industry median. Based on the distribution chart, Accendra Health ranks #93 out of 118 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Accendra Health has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's ROC (Joel Greenblatt) % compare to FOCL and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #93 out of 118 companies for ROC (Joel Greenblatt) %. This places Accendra Health in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 15.35. Accendra Health's value of 18.54% is 20.8% above this benchmark. While the company's 10-year median is 9.39 vs. the industry median of 15.35, Accendra Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Distribution company?
The median ROC (Joel Greenblatt) % among Medical Distribution companies is 15.35, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accendra Health's current ROC (Joel Greenblatt) % of 18.54% is 20.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Accendra Health and its competitors. For the Medical Distribution industry, the median ROC (Joel Greenblatt) % is 15.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accendra Health's current ROC (Joel Greenblatt) % is 18.54%, which is 97% above median its own 10-year median of 9.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.02, compared to a current price of $3.59 — trading 28.5% below its estimated fair value. The current ROC (Joel Greenblatt) % is 18.54%, which is 97% above median its 10-year median of 9.39 and 20.8% above the Medical Distribution industry median of 15.35. Accendra Health's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Accendra Health (ACH), the current ROC (Joel Greenblatt) % is 18.54% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accendra Health (ACH) Overvalued in 2026?
Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued.
The current stock price of $3.59 is trading 28.5% below its estimated GF Value™ of $5.02.
GuruFocus considers Accendra Health to be Modestly Undervalued.
Key valuation signals for ACH:
ROC (Joel Greenblatt) %: 18.54% (97% above median its 10-year median of 9.39)
GF Value™: $5.02 vs. price of $3.59 (28.5% below fair value)
Industry Position: 20.8% above the Medical Distribution median (#93 of 118)
No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
61GF Score
Get the complete analysis for ACH
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACH has been successfully added to your 
